Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Receptor Antagonist”

Showing 4 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002864
What this trial is testing

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 667
Testing effectiveness (Phase 2)Study completedNCT00728949
What this trial is testing

Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 93
Not applicableUnknownNCT06346457
What this trial is testing

Breast Cancer & Antiestrogenic Therapy & Brain

Who this might be right for
Breast Cancer FemaleHealthy FemaleMenopause+1 more
International Research Training Group 2804 180
Testing effectiveness (Phase 2)Study completedNCT02911844
What this trial is testing

Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 5

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation